소아 피부 및 연조직 감염 환자에서의 황색포도알균의 항생제 감수성의 변화: 2010년부터 2018년까지 단일기관에서의 경험
Changing Susceptibility of Staphylococcus aureus in Children with Skin and Soft Tissue Infections: a Single Center Experience from 2010 to 2018
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: 피부 및 연조직 감염(skin and soft tissue infections [SSTIs])의 가장 흔한 원인은 황색포도알균(Staphylococcus aureus)이다. 본 연구는 19세 미만의 SSTI 환자에서 분리된 황색포도알균의 항생제 감수성의 변화추이를 알아보고자 하였다. 방법: 황색포도알균이 분리된 소아청소년 지역사회관련 SSTI 환자에서 후향적 관찰연구를 시행하였다. 미생물학 및 인구학적 자료를 수집하고, 항생제 감수성의 변화추이를 관찰하였다. 결과: 2010년 1월부터 2018년 12월까지 총 807개의 지역사회관련 황색포도알균이 연구에 포함되었다. Oxacillin에 대한 감수성은 전반적으로 증가하여(P<0.001) 2018년에는 75.0%였다. Trimethoprim/sulfamethoxazole과 tetracycline에 대한 감수성은 매우 높게 유지되어 2018년 각각 97.6%와 95.2%였다. 만 1–5세 연령군에서 만 6–18세 연령군에 비해 oxacillin 감수성이 유의하게 낮았다(53.4% vs. 75.0%, P<0.001). 결론: 소아청소년의 지역사회관련 SSTI의 원인이 된 황색포도알균 중 메티실린내성 황색포도알균의 비율이 감소하고 있는 것으로 보인다. 임상의는 경험적 항생제를 선택할 때 지역적 항생제 감수성 양상을 확인해야 한다.
Abstract
Purpose: Staphylococcus aureus is a major cause of skin and soft tissue infections (SSTIs). This study aimed to determine the temporal trends in antibiotic susceptibility of S. aureus in SSTI patients aged <19 years. Methods: This retrospective observational study was conducted in pediatric patients with SSTI caused by community-associated S. aureus. Microbiologic and demographic data were collected, and the trends of antibiotic susceptibility results were evaluated. Results: From January 2010 to December 2018, a total of 807 S. aureus isolates were included. An overall increase in susceptibility of isolates to oxacillin was noted (P<0.001), with 75.0% of isolates being oxacillin-susceptible in 2018. S. aureus remained highly susceptible to trimethoprim/sulfamethoxazole and tetracycline, with 97.6% and 95.2% isolate susceptibility in 2018, respectively. Isolates from younger children aged 1 to 5 years had a significantly lower rate of susceptibility to oxacillin than older children aged 6 to 18 years (53.4% vs. 75.0%, P<0.001). Conclusions: The proportion of methicillin-resistant S. aureus isolates appears to decrease in pediatric patients with community-associated SSTI caused by S. aureus. Clinicians should be aware of regional susceptibility patterns when choosing empirical regimens.
참고문헌 (29)
- Moet GJ, "Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)", Diagn Microbiol Infect Dis, 57, pp.7~13 (2007)
- Edelsberg J, "Trends in US hospital admissions for skin and soft tissue infections", Emerg Infect Dis, 15, pp.1516~1518 (2009)
- Pallin DJ, "Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus", Ann Emerg Med, 51, pp.291~298 (2008)
- Chuang YY, "Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia", Lancet Infect Dis, 13, pp.698~708 (2013)
- Ma SH, "Meticillin-resistant Staphylococcus aureus clones with distinct clinical and microbiological features in a Korean community", J Med Microbiol, 56, pp.866~868 (2007)
- 최영준, "소아 황색포도알균 감염증의 임상양상에 대한 고찰: 지역사회 관련 메티실린 내성 황색포도알균 감염을 중심으로", Pediatric Infection and Vaccine, 16(2), pp.150~161 (2009), 대한소아감염학회
- Velasco D, "Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus", J Antimicrob Chemother, 55, pp.379~382 (2005)
- Klein E, "Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005", Emerg Infect Dis, 13, pp.1840~1846 (2007)
- Landrum ML, "Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010", JAMA, 308, pp.50~59 (2012)
- Sutter DE, "Changing susceptibility of Staphylococcus aureus in a US pediatric population", Pediatrics, 137, pp.e20153099~ (2016)
- Johnson AP, "Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years", J Antimicrob Chemother, 67, pp.802~809 (2012)
- European Centre for Disease Prevention and Control, "Antimicrobial resistance (EARS-Net)", ECDC. Annual epidemiological report for 2014, pp.1~14 (2018), ECDC
- Moon HW, "Antimicrobial susceptibility profiles of Staphylococcus aureus isolates classified according to their origin in a tertiary hospital in Korea", Am J Infect Control, 42, pp.1340~1342 (2014)
- Kim ES, "Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea", PLoS One, 9, pp.e114127~ (2014)
- Baek YS, "Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea", Int J Dermatol, 55, pp.e191~e197 (2016)
- 임선희, "단일 기관에서 2002년부터 2016년까지 발생한 소아 황색포도알균 균혈증의 역학", Pediatric Infection and Vaccine, 26(1), pp.11~21 (2019), 대한소아감염학회[DOI]
- 신선미, "Prevalence of Antibiotic Use for Pediatric Acute Upper Respiratory Tract Infections in Korea", Journal of Korean Medical Science, 30(5), pp.617~624 (2015), 대한의학회
- 박정민, "Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period", Annals of Dermatology, 28(4), pp.470~478 (2016), 대한피부과학회
- 황윤하, "아토피피부염 소아의 피부집락균 중 Staphylococcus aureus 의 빈도와 항생제 감수성에 관한 연구", Allergy Asthma & Respiratory Disease, 5(1), pp.21~26 (2017), 대한 소아알레르기 호흡기학회[DOI]
- Kaplan SL, "Treatment of community-associated methicillin-resistant Staphylococcus aureus infections", Pediatr Infect Dis J, 24, pp.457~458 (2005)
- Stevens DL, "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America", Clin Infect Dis, 59, pp.147~159 (2014)
- Herigon JC, "Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999–2008", Pediatrics, 125, pp.e1294~e1300 (2010)
- Khamash DF, "Increasing clindamycin and trimethoprim-sulfamethoxazole resistance in pediatric Staphylococcus aureus infections", J Pediatric Infect Dis Soc, 8, pp.351~353 (2019)
- Song YK, "A national pharmacoepidemiological study of antibiotic use in Korean paediatric outpatients", Arch Dis Child, 102, pp.660~666 (2017)
- Levi N, "Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis", Pediatrics, 123, pp.e297~e304 (2009)
- Williams DJ, "Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections", Pediatrics, 128, pp.e479~e487 (2011)
- Miller LG, "Clindamycin versus trimethoprimsulfamethoxazole for uncomplicated skin infections", N Engl J Med, 372, pp.1093~1103 (2015)
- Grossman ER, "Tetracyclines and permanent teeth: the relation between dose and tooth color", Pediatrics, 47, pp.567~570 (1971)
- Friedman ND, "The negative impact of antibiotic resistance", Clin Microbiol Infect, 22, pp.416~422 (2016)
